Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jun 10;42(30):3593–3605. doi: 10.1200/JCO.24.01001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG A5. — DoR: (A) among confirmed responders and (B) among all responders. The efficacy population included all patients who had undergone random assignment. Included in this analysis were the 55 (confirmed) and 62 (including unconfirmed) responders (of the 206 patients with measurable disease at baseline by RECIST, v1.1) in the subcutaneous group and the 57 (confirmed) and 69 (including unconfirmed) responders (of 212 patients) in the intravenous group, respectively. Tick marks indicate censoring of data. DoR, response duration; NE, not estimable.